Global, multi-center, repeat-dose, phase 2 study of RZ358 (ersodetug), an insulin receptor antibody, for congenital hyperinsulinism.

Demirbilek H., Melikyan M., Iotova V., Galcheva S., Ozbek M. N., Dastamani A., ...More

Med (New York, N.Y.), vol.6, no.6, pp.100611, 2025 (ESCI, Scopus)

• Publication Type: Article / Article
• Volume: 6 Issue: 6
• Publication Date: 2025
• Doi Number: 10.1016/j.medj.2025.100611
• Journal Name: Med (New York, N.Y.)
• Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
• Page Numbers: pp.100611
• Hacettepe University Affiliated: Yes